PharmaVigilant Launches PaySite 2.0, A New Site Payment System
PharmaVigilant
today unveiled PaySite 2.0, a new Site Payment System that provides a complete dashboard to the sponsor, enabling them to program site payments based upon performance and individual site contracts. With PaySite, sponsors can determine payments made both graphically and within defined reports, and generate site letters defining the payouts and the criteria associated with the payment. Combined, this functionality streamlines the site payment process, improving the relationship between the sponsor and the site.
PaySite has no limitations regarding combinations; complex compensation programs can be easily defined and implemented in any currency. Information can be exported in sponsors’ accounting systems to further streamline the payment process.
“One of the keys to enhancing site/sponsor relationships is paying sites on time. As sponsors’ accounting processes elongate in complexity and time, site payments get extended, creating stress on the relationship,” said James DeSanti, founder and chief executive officer, PharmaVigilant. “PaySite reduces the time upfront by creating payment reports on-demand, or with manual overrides when required.”
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025